Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Serge Van Calenbergh
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
40
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor
01 February 2007 → 31 January 2009
Cancer sciences xs47 r261 (code 8461)
Funding: European funding: various
01 October 2023 → 30 September 2025
Cofunding core facility - NMR Expertise Centre
Funding: Regional and community funding: Special Research Fund
01 January 2024 → 31 December 2024
Design and synthesis of inhibitors of the MEP pathway
Fellow: Thibaut Quennesson
Funding: Regional and community funding: Special Research Fund
01 January 2007 → 30 December 2012
Development of alpha-subsituted fosmidomycin analogues as antimalarial DOXP reductoisomerase inhibitors
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 30 September 2010
Development of KRN 7000 analogues with an improvement selectivity profile
Fellow: Matthias Trappeniers
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2010 → 31 December 2015
Development of methotrexate conjugates for the identification of new intracellular targets via the Maspit technology
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 30 September 2012
Development of methotrextate conjugates for the identification of new intracellular targets via the Maspit technology
Funding: Regional and community funding: Special Research Fund
01 July 2008 → 01 January 2037
DiscoverE
Funding: Regional and community funding: Industrial Research Fund
01 January 2024 → 31 December 2025
Drug discovery for neglected diseases
Funding: Regional and community funding: Special Research Fund
16 October 2023 → 15 October 2024
Evaluation of a new treatment against "blackhead" disease in turkeys (POULTRY 2)
Funding: Regional and community funding: Industrial Research Fund
01 June 2015 → 31 May 2017
Expedient purification of bioactive small molecules and/or their PEG conjugates using automated preparative HPLC
Funding: Regional and community funding: Special Research Fund
01 April 2020 → 30 September 2024
Exploiting the methylerythritol phosphate pathway as a source of drug targets for novel anti-infectives
Funding: European funding: framework programme
01 January 2020 → 31 October 2025
Identification of adaptive mechanisms leading to reduced antibiotic susceptibility in bacterial biofilms using experimental evolution and machine learning approaches
Funding: Regional and community funding: Special Research Fund
15 July 2023 → 14 October 2024
Identification of optimized Aurora Kinase A PROTACs with suitable PK properties for in vivo proof-of-concept studies (OPTIMAPK).
Funding: Regional and community funding: Industrial Research Fund
01 January 2018 → 31 December 2021
Modified 7-deazapurine nucleoside analogues for the treatment of human African trypanosomiasis: towards a strong proof-of-concept.
Funding: Research Foundation - Flanders (FWO)
03 August 2020 → 30 June 2022
Novel treatment for blackhead disease in turkeys
Funding: Regional and community funding: Industrial Research Fund
01 July 2015 → 31 January 2019
Pharmacological feasibility of a drug discovery opportunity for a novel cancer immunotherapy
Funding: Regional and community funding: Industrial Research Fund
01 May 2018 → 30 April 2022
Phar-NMR: Superconducting Fourier 400 MHz NMR Spectrometer as Indispensable Tool in Pharmaceutical Research
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2016
Structure-activity studies around Hamamelitannin a natural fabric with attractive quorum sensing inhibitory activity
Fellow: Arno Vermote
Funding: Regional and community funding: IWT/VLAIO
01 January 2015 → 31 December 2020
Study of the interaction between the dopamine D2-like receptors and the μ opioid receptor
Funding: Research Foundation - Flanders (FWO)
01 October 2009 → 01 March 2011
Synthese van suikergemodificeerde a-galactosylveramide-analogen als Th1- polariserende NKT-vel antigenen.
Fellow: Shari Celen
Funding: Regional and community funding: Special Research Fund
01 October 2010 → 30 September 2014
Synthesis and evaluation of new antimalarials tackling a unique biosynthetic pathway for isoprenoid synthesis in P. falciparum.
Funding: Regional and community funding: Special Research Fund
01 October 2014 → 30 September 2018
Synthesis of a-GalCer analogues as tools to elucidate the mechanisms of NKT cell polarization.
Fellow: Charlotte Courtens
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2011 → 30 September 2015
Synthesis of sugar-modified alpha-galactosylceramide analogs as Th1-polarizing NKT-cell antigens
Funding: Regional and community funding: Special Research Fund
01 October 2011 → 30 June 2016
Synthesis of Th1-polarizing NKT-cell antigens derived from alpha-galactosyl ceramide
Fellow: Joren Guillaume
Funding: Regional and community funding: IWT/VLAIO
01 October 2013 → 30 September 2017
Synthesis of therapeutically useful compounds featuring branched-chain carbohydrate moiety
Fellow: Fabian Hulpia
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 March 2013 → 30 September 2016
Synthetic optimization of fosmidomycin (analogues) towards selection of a preclinical candidate that combines promising pharmacodynamic bioacailability properties.
Fellow: Lijun Song
Funding: Regional and community funding: Special Research Fund
01 October 2019 → 31 October 2020
Targeting the degradation of proteins involved in neuroblastoma and autoinflammatory diseases with bivalent ligands.
Fellow: Simon Krols
Funding: Regional and community funding: Special Research Fund
01 November 2020 → 31 October 2024
Targeting the degradation of proteins involved in neuroblastoma with bivalent ligands.
Fellow: Simon Krols
Funding: Research Foundation - Flanders (FWO)
01 November 2020 → 28 February 2021
Toxoplasmosis: leveraging active purine nucleoside uptake as new therapeutic strategy.
Fellow: Fabian Hulpia
Funding: Research Foundation - Flanders (FWO)
As
Copromotor
03 July 2012 → 31 August 2017
3D Structural Platform for Chemical Excellence.
Funding: Research Foundation - Flanders (FWO)
01 January 2010 → 31 December 2015
Development of a new, miniaturized 18F marking method for proteins and peptides with 18 F-FDG as a building block
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2018
Dynamic visualization of TCR-induced NKT cell arrest and anergy induction in vivo
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2016
Fighting infectious diseases with combination therapy: targetting sociomicrobiological processes to circumvent antimicrobial resistance
Funding: Regional and community funding: various
01 January 2013 → 31 December 2016
in vivo visualization of NKT cell-mediated anti-tumor activity
Funding: Funding by bilateral agreement (private and foundations)
01 January 2009 → 31 December 2014
Molecular elucidation of polarized cytokine responses induced by structural changes in glycolipid antigenten presented by CD1d.
Funding: Research Foundation - Flanders (FWO)
01 January 2009 → 30 September 2014
Penetration of antimicrobial agents into biofilms and use of quorum sensing inhibitors as novel anti-biofilm compounds
Funding: Regional and community funding: Special Research Fund
01 October 2021 → 30 September 2025
Targeting transcription factor addiction in acute leukemia (TaTFAL)
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2018
The DOXP pathway as novel target for antibacterial chemotherapy
Funding: Research Foundation - Flanders (FWO)
01 January 2024 → 31 December 2027
Uncaging the potential of photopharmacology for the treatment of epilepsy
Funding: Research Foundation - Flanders (FWO)